Sitemap

Home
sitemap
About
- Amgen History Awards and Accolades How We Operate
  - Corporate Governance
    - Board of Directors Guidelines for Director Qualifications and Evaluations Duties and Responsibilities of the Lead Independent Director Amgen Board of Directors Corporate Governance Principles Audit Committee Compensation and Management Development Committee Corporate Responsibility and Compliance Committee Equity Award Committee Executive Committee Charter Governance and Nominating Committee Board of Directors Code of Conduct Staff Code of Conduct Supplier Code of Conduct Code of Ethics for CEO and Senior Financial Officers Policy on Executive Compensation in Restatement Situations Rights Plan Policy
    Policies, Practices and Disclosures
    - Human Rights Commitment Ethical Research
      - Global Code of Ethics for Clinical Trials Clinical Trial Transparency, Data Sharing and Disclosure Practices
        
        Clinical Trial Data Sharing Request
        
        Amgen Guidelines for Publications Amgen Position Statement on Stem Cell Research Biobanking of Human Samples Adverse Event and Product Complaint Reporting Commitment to the Ethical Use of Animals in Research Amgen Statement on Compendia R&D Gifts Policy
      Responsible Marketing and Product Information
      - Our Approach to Responsible Marketing Direct-to-Consumer (DTC) Advertising Interactions With Healthcare Providers Post-Marketing Commitments/Post-Marketing Requirements Driving a Compliant Workforce Interactions with Patient Groups Third Party Sales Interactions with the Public
      Corporate Giving
      Climate Change Position Statement Business Conduct
      - Quality Protection of Personal Information Insider Trading Conflicts of Interest Antitrust and Unfair Competition Political Activities Anti-Bribery and Anti-Corruption
      Work Environment
      - Safe and Healthy Workplace Environment, Health, and Safety Equal Employment Opportunity Non-Discrimination and Harassment Free Workplace Compliance Reporting and Non-Retaliation
      International Trade
      - Economic Sanctions, Embargoes, and Boycotts Export and Import Control Laws
      Transparency Disclosures
      - Donation and Grant Recipients
        
        Independent Medical Education and Healthcare Donations Amgen Foundation Grants Amgen Funding to European Patient Organizations
        
        Donations & Grant Disclosures FAQs
        
        Political Contributions U.S. Healthcare Professionals and Entities EFPIA Disclosures
      Privacy Pledge to Patients
  Leadership
  - Senior Management
    Board of Directors
    Scientific Advisory Boards
  Mission and Values
KRAS Information Center
Science
- Clinical Trials
  - About Clinical Trials Clinical Trial Transparency, Data Sharing and Disclosure Practices
    - Clinical Trial Data Sharing Request
    Clinical Out-of-Hours Support Program Clinical Trial Diversity and Representation
    - Amgen's Commitment to Clinical Trial Diversity Clinical Trial Diversity for PhRMA
    Information for Healthcare Professionals
    - Research Philosophy Investigator Resources Investigator Survey
  Manufacturing
  - Innovation Quality Reliability Stories
  Amgen Science Podcasts
  - Human Data Era Podcast
    The Innovating Clinical Trials Podcast
    The Generative Biology Revolution Podcast
    Undruggable DNA Unlocked
  Research and Development Strategy
  - AI & Data Science Clinical Trial Innovation Human Data Multispecifics & Other Modalities
  Scientific Advisory Boards Scientific Community Initiatives
  - Educational Outreach Program Postdoctoral Fellows Program
    Scientific Conferences Program Start-Up Network Program
Teneobio
Products
- Counterfeit Drug Statement Global Patient Safety
  - Who We Are Our Commitment What We Do Adverse Event and Product Complaint Reporting
  Safety Data Sheets
Responsibility
- Environmental, Social & Governance Report 2022 Environment, Social and Governance Strategy Healthy People
  - Access to Healthcare
    - U.S. Reimbursement Support Services and Financial Assistance Programs Access to Healthcare Initiatives Outside the U.S.
      - Pricing and Patient Support Health System Strengthening Product Donations R&D, Manufacturing and Distribution
      Access to Investigational Medicines Our Approach to Pricing, Access and Affordability
      - Access Approaches, Treatments, and Collaborations
        
        Responsible Approach to Pricing
        
        Amgen’s Approach to Responsible Pricing
        
        Value-based Contracts Biosimilars Access to Medicine and Patient Support Programs
        
        Transformative Treatments, Approaches, and Technology
        
        Precision and Personalized Medicine Digital Health Solutions
        
        Shaping the Future of Healthcare
        
        Investing in Innovation to Transform Therapies in Healthcare Health System Solutions
    Health Equity
    - Health Equity Challenge Health Equity Overview
  Healthy Society
  - Amgen Foundation and Community Investment
    - Amgen Foundation
      - Amgen Foundation Grants
        
        Amgen Foundation Grant Guidelines Letter of Inquiry Checklist Grant Application Checklist Amgen Foundation Grant FAQs
      Staff Engagement U.S. Healthcare Donations
      - Eligibility Criteria Healthcare Donations FAQs Contact Us
      Equipment Donations U.S Non-Healthcare Donations and Sponsorships
      Independent Medical Education Funding
      - Independent Medical Education FAQs Budget Instructions Contact Us
      Amgen Patient Advocacy and Strategic Alliances
      - Amgen Supported Initiatives Every Patient Counts, Every Story Matters
    Diversity, Inclusion and Belonging
    - Amgen's Commitment to Diversity, Inclusion and Belonging
    Human Capital Management
    - Safety Wellness
    Responsible Sourcing
  Healthy Planet
  - Environmental Sustainability
    - Performance
      - Carbon Water Waste Targets
      2027 Plan Sustainable by Design
      - Product Sustainability Green Buildings
      Case Studies
    Supplier Sustainability
    - California Supply Chain Transparency Act
  A Healthy Amgen
  - Business Ethics and Compliance
    - Annual Declaration of Compliance Elements of an Effective Compliance Program Amgen’s Culture of Compliance Code of Conduct Corporate Compliance Policies Reporting a Concern
    Ethical Research Cybersecurity and Data Privacy
  Reporting and Metrics
  - Summary of Data CDP Patents for Our Five Top Selling Products Archived Reports
    - 2019 Responsibility Highlights Report
      - Access to Medicine Business Ethics Community Environment Forward Looking Statements Letter From Bob Bradway Our Response to COVID-19 Reporting and Metrics Workplace
Executive Compensation
Newsroom
- Image Library Company Statements
  Global Contact Info
Partners
- Academic Collaborations
  - New Requests
    - Special Instructions for Australia and New Zealand
    Requests for Refill or Amendment
    - Special Instructions for Australia and New Zealand
    Scientific Report or Notice of Invention error page
  Suppliers
  - Supplier Diversity
    - Amgen's Statement on Supplier Diversity Supplier Diversity Program at Amgen Our Commitment Registering With Amgen Amgen’s Sourcing Categories Affiliations
    Supplier Resources
    - Supplier Procurement Guidelines Supplier Code of Conduct Conflict Minerals Policy Supplier Invoice Guidelines Supplier Shipping and Receiving Supplier Contact Information Existing Supplier On-Boarding Supplier Terms and Conditions
  Wholesalers
Amgen Binding Corporate Rules
Global Hotline for Ukrainian Refugee Patients Participating in an Amgen Clinical Trial
Community Guidelines
Amgen Worldwide
Contact Us
- Locations Product Inquiries Website Feedback
Privacy Statement
- amgen-stories
ChemoCentryx Notification
- ChemoCentryx Privacy ChemoCentryx Terms of Use
Global Privacy Statement Directory
Terms of Use
Information Regarding the Offer for Horizon Therapeutics
_bin